Skip to main content
Log in

Knocking out the regulatory beta subunit of protein kinase CK2 in mice: Gene dosage effects in ES cells and embryos

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Knocking out the regulatory β subunit of protein kinase CK2 in mice leads to early embryonic lethality. Heterozygous CK2β (CK2β+/−) knockout mice do not show an obvious phenotype. However, the number of heterozygous offsprings from CK2β+/− inter-crossings is lower than expected, meaning that some heterozygous embryos do not survive. Interestingly, CK2β+/− ES (Embryonic Stem) cells express a considerably lower level of CK2β than wild-type ES cells, whereas the level of CK2β in organs from heterozygous adult mice does not significantly differ from those of wild-type mice. The data suggest a compensatory mechanism that adjusts CK2β levels during development in the majority of, but not in all, cases (Mol Cell Biol {23:} 908–915, 2003).

In order to find an explanation for the gene dosage effect observed for heterozygous offsprings, we analysed embryos at mid-gestation (E10.5) as well as wild-type and CK2β+/− ES cells for differences in growth rate and response to different stress agents. Analysis of E10.5 embryos generated from heterozygous matings revealed about 20% of smaller retarded CK2β+/− embryos. No correlation between CK2β levels in normal looking and retarded CK2β+/− embryos were found. However, a different post-translational form of CK2β protein has been detected in these retarded embryos. Cellular parameters such as growth rate and G1-, G2-checkpoints in ES cells were identical in both wild-type and CK2β+/− cells. When ES cells were injected to induce differentiated teratocarcinoma in syngenic mice, the size of the tumours correlated with the level of CK2β.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kusk M, Ahmed R, Thomsen B, Bendixen C, Issinger OG, Boldyreff B: Interaction of protein kinase CK2beta subunit within the holoenzyme and with other proteins. Mol Cell Biocehm 191: 51–58, 1999

    Google Scholar 

  2. Grein S, Raymond K, Cochet C, Pyerin W, Chambaz E, Filhol O: Searching interaction partners of protein kinase CK2beta subunit by two-hybrid screening. Mol Cell Biochem 191: 105–109, 1999

    PubMed  Google Scholar 

  3. Chen M, Li D, Krebs EG, Cooper JA: The casein kinase II beta subunit binds to Mos and inhibits Mos activity. Mol Cell Biol 17: 1904–1912, 1997

    PubMed  Google Scholar 

  4. Guerra B, Issinger OG, Wang JY: Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2. Oncogene 22(32): 4933–4942, 2003

    PubMed  Google Scholar 

  5. Bidwai AP, Reed JC, Glover CVC: Cloning and disruption of CKB1, the gene encoding the 38-kDA beta subunit of Saccharomyces cerevisiae casein kinase II (CKII). J Biol Chem 270: 10395–10404, 1995

    PubMed  Google Scholar 

  6. Reed JC, Bidwai AP, Glover CVC: Cloning and disruption of CKB2, the gene encoding the 32-kDa regulatory beta-subunit of Saccharomyces cerevisiae casein kinase II. J Biol Chem 269: 18192–18200, 1994

    PubMed  Google Scholar 

  7. Roussou I, Draetta G: The Schizosaccharomyces pombe casein kinase II alpha and beta subunits: Evolutionary conservation and positive role of the beta subunit. Mol Cell Biol 14: 576–586, 1994

    PubMed  Google Scholar 

  8. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J: Functional genomic analysis of C-elegans chromosome I by systemic RNA interference. Nature 408: 325–330, 2000

    PubMed  Google Scholar 

  9. Jauch E, Melzig J, Brkulj M, Raabe T: In vivo functional analysis of Drosophila protein kinase casein kinase 2 (CK2) beta-subunit. Gene 298: 29–39, 2000

    Google Scholar 

  10. Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger OG, Boldyreff B: Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 23: 908–915, 2003

    PubMed  Google Scholar 

  11. Homma MK, Li D, Krebs EG, Yuasa Y, Homma Y: Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein. Proc Natl Acad Sci USA 99: 5959–5964, 2002

    PubMed  Google Scholar 

  12. Songyang Z, Lu KP, Kwon YT, Tsai LH, Filhol O, Cochet C, Brickey DA, Soderling TR, Bartleson C, Graves DJ, DeMaggio AJ, Hoekstra MF, Blenis J, Hunter T, Cantley LC: A structural basis for substrate specificities of protein Ser/Thr kinases: Primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol 16: 6486–6493, 1996

    PubMed  Google Scholar 

  13. Sabapathy K, Klemm M, Jaenisch R, Wagner EF: Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J 16: 6217–6229, 1997

    PubMed  Google Scholar 

  14. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW: DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287: 1824–1827, 2000

    PubMed  Google Scholar 

  15. Larue L, Antos C, Butz S, Huber O, Delmas V, Dominis M, Kemler R: A role for cadherins in tissue formation. Development 122: 3185–3194, 1996

    PubMed  Google Scholar 

  16. Martel V, Filhol O, Nueda A, Cochet C: Dynamic localization/association of protein kinase CK2 subunits in living cells: A role in its cellular regulation? Ann NY Acad Sci 973: 272–277, 2002

    PubMed  Google Scholar 

  17. Meggio F, Pinna LA: One-thousand-and-one substrates of protein kinase CK2? FASEB J 17: 349–368, 2003

    PubMed  Google Scholar 

  18. Muenstermann U, Fritz G, Seitz G, Lu YP, Schneider HR, Issinger OG: Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. Eur J Biochem 189: 251–217, 1990

    PubMed  Google Scholar 

  19. Gotz C, Scholtes P, Prowald A, Schuster N, Nastainczyk W, Montenarh M: Protein kinase CK2 interacts with a multi-protein binding domain of p53. Mol Cell Biochem 191: 111–120, 1999

    PubMed  Google Scholar 

  20. Teitz T, Eli D, Penner M, Bakhanashvili M, Naiman T, Timme TL, Wood CM, Moses RE, Canaani D: Expression of the cDNA for the beta subunit of human casein kinase II confers partial UV resistance on xeroderma pigmentosum cells. Mutat Res 236: 85–97, 1990

    PubMed  Google Scholar 

  21. Kato T, Delhase M, Hoffmann A, Karin M: CK2 is a terminal IkappaB kinase responsible for NF-kappaB activation during UV response. Mol Cell 12: 829–839, 2003

    PubMed  Google Scholar 

  22. Romieu-Mourez R, Landesmann-Bollag E, Seldin DC, Sonenshein GE: Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cell. Cancer Res 62: 6770–6778, 2002

    PubMed  Google Scholar 

  23. Toczyski DP, Galgoczy DJ, Hartwell LH: CDC5 and CKII control adaptation to the yeast DNA damage check point. Cell 90: 1097–1106, 1997

    PubMed  Google Scholar 

  24. Stalter G, Siemer S, Becht E, Ziegler M, Remberger K, Issinger OG: Asymmetric expression of protein kinase CK2 subunits in human kidney tumors. Biochem Biophys Res Commun 202: 141–147, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brigitte Boldyreff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blond, O., Jensen, H.H., Buchou, T. et al. Knocking out the regulatory beta subunit of protein kinase CK2 in mice: Gene dosage effects in ES cells and embryos. Mol Cell Biochem 274, 31–37 (2005). https://doi.org/10.1007/s11010-005-3117-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-005-3117-x

Keywords

Navigation